Scarica l'app Stockscreener
1.25
2.46%
0.03
Dopo l'orario di chiusura:
1.26
0.01
+0.80%
Tevogen Bio Holdings Inc Borsa (TVGN) Ultime notizie
Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Sees Large Growth in Short Interest - Defense World
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target DiscoveryRIVER COUNTRY - RIVER COUNTRY - NEWS CHANNEL NEBRASKA
Tevogen Uses AI To Advance EBV-Specific T Cell Therapy Toward Clinical Trials - Nasdaq
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered - Bluefield Daily Telegraph
Breakthrough: AI Technology Accelerates EBV Cancer Treatment Discovery at Tevogen - Stock Titan
Tevogen Bio (NASDAQ:TVGN) Given Buy Rating at D. Boral Capital - Defense World
Tevogen Bio Expands Headquarters To Support Growth In AI And Generics & Biosimilars Initiatives - Nasdaq
Tevogen expands headquarters in Warren, New Jersey - Yahoo Finance
Tevogen’s lease agreement will double headquarters footprint at Warren HQ - ROI-NJ
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives - The National Law Review
Tevogen Bio Expands Headquarters to Enhance R&D and Operational Efficiency with Support from Microsoft - Nasdaq
Tevogen Transforms into AI Powerhouse: $36B Revenue Target as Company Doubles HQ Size - Stock Titan
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Shares Purchased by Northern Trust Corp - Defense World
tevogen bio expands office lease in new jersey with key amendment - Investing.com Canada
Tevogen Bio Expands Office Space in New Jersey - TipRanks
Tevogen Bio expands AI in immunotherapy development By Investing.com - Investing.com South Africa
Tevogen Bio expands AI in immunotherapy development - Investing.com India
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships - The Manila Times
Tevogen Bio Holdings Inc. Unveils Tevogen.AI™ Initiative to Enhance Immunotherapy Development with Advanced AI Technologies - Nasdaq
Tevogen Details its Artificial Intelligence Initiative, - GlobeNewswire
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered ... - Bluefield Daily Telegraph
Tevogen Teams Up with Microsoft to Transform Healthcare: New AI Platform Targets $5T Industry - Stock Titan
Tariff Twist and PCE Ahead—Markets Hold Key Support - The Globe and Mail
This Raytheon Rival Is on Track to Hit New 52-Week Highs - The Globe and Mail
PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla - The Globe and Mail
Is IonQ Stock a Buy Now? - The Globe and Mail
Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Sees Large Drop in Short Interest - Defense World
4 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - The Globe and Mail
Tevogen Peports Plans to Increase the Target Population for TVGN 489 - Insider Monkey
Tevogen expands target for COVID treatment to seniors By Investing.com - Investing.com India
Tevogen expands target for COVID treatment to seniors - Investing.com Australia
Tevogen Bio Plans to Expand Specialty Care Pipeline to - GlobeNewswire
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow - The Globe and Mail
Tevogen to Update on Robust Portfolio Assets, Business - GlobeNewswire
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting - The Manila Times
Tevogen Bio Holdings Inc. to Provide Key Updates Ahead of Annual Meeting on June 23, 2025 - Nasdaq
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited ... - Bluefield Daily Telegraph
Tevogen Unveils Massive $10B Portfolio Valuation and AI Expansion Ahead of Critical June Meeting - Stock Titan
Nvidia-Foxconn AI Alliance Could Disrupt the Supercomputer Market—What’s at Stake for Investors - The Globe and Mail
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Stock Position Raised by Barclays PLC - Defense World
Tevogen Bio Holdings Inc. SEC 10-Q Report - TradingView
Tevogen Bio (NASDAQ:TVGN) Given “Buy” Rating at D. Boral Capital - Defense World
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - The Manila Times
Tevogen Bio Positions Itself as a Leader in Cost-Efficient Healthcare Amid Global Pharmaceutical Competition - Nasdaq
JPMorgan Chase & Co. Has $40,000 Stake in Tevogen Bio Holdings Inc. (NASDAQ:TVGN) - Defense World
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):